Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial. Implication for subsequent local excision

被引:77
作者
Bujko, K
Nowacki, MP
Nasierowska-Guttmejer, A
Kepka, L
Winkler-Spytkowska, B
Suwinski, R
Oledzki, J
Stryczynska, G
Wieczorek, A
Serkies, K
Rogowska, D
Tokar, P
机构
[1] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Radiotherapy, PL-02781 Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Colorectal Canc, PL-02781 Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol, PL-02781 Warsaw, Poland
[4] Silesian Oncol Ctr, Dept Radiotherapy, Wroclaw, Poland
[5] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Radiotherapy, Gliwice, Poland
[6] Med Acad Poznan, Dept Radiotherapy, PL-60780 Poznan, Poland
[7] Holycross Oncol Ctr, Dept Radiotherapy, Kielce, Poland
[8] Med Acad Gdansk, Dept Radiotherapy, Gdansk, Poland
[9] Med Acad, Dept Radiotherapy, Szczecin, Poland
[10] Ctr Oncol, Dept Radiotherapy, Opole, Poland
关键词
rectal cancer; nodal metastases; preoperative chemoradiation; local excision;
D O I
10.1016/j.radonc.2005.04.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and,purpose: For patients with rectal cancer treated with full thickness local excision the risk of mesorectal nodal metastases has to be very low. The aim was to assess this risk after preoperative radiotherapy in relation to pathological T-category. Patients and methods: Three hundred sixteen patients with resectable cT3-4 low rectal carcinoma were randomised to receive either preoperative 5 x 5 Gy irradiation with subsequent surgery performed within 7 days or chemoradiation (50.4, 1.8 Gy per fraction plus,bolus 5-fluorouracil and leucovorin) followed by surgery after 4-6 weeks. The pathological reports of patients who fulfilled entry criteria and had preoperative irradiation followed by transabdominal surgery were analysed. Results: Significant downstaging of primary tumour (P < 0.001) and of nodal disease (P = 0.007) was observed after chemoradiation in comparison with short-course irradiation. In chemoradiation group, for patients with complete pathological response and for ypT1 category, the rate of nodal metastases was low -5% (95% confidence interval [CI] 0-14%) and 8% (95% CI 0-24%), respectively. The rate of ypN-positive disease in chemoradiation group was similar to that recorded in short-course irradiation group for ypT2 category 26% (95% CI 14-38%) vs. 28% (95% CI 16-40%), P = 0.83 and for ypT3-4 category 55% (95% CI 41-69%) vs. 64% (95% CI 54-74%), respectively, P = 0.37. For ypT2 category after chemoradiation, the rate of nodal disease remained high even in subgroup with low residual cancer cells density (20%, 95% CI 4-36%). Conclusions: For patients with tumours downstaged by chemoradiation to ypT0 and ypT1 full thickness local excision may be considered as an acceptable approach, because the risk of mesorectal lymph nodes metastases is low. The selection criteria for preoperative radio(chemo)therapy and local excision are discussed. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 39 条
  • [1] The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after preoperative chemoradiation therapy
    Barbaro, B
    Schulsinger, A
    Valentini, V
    Marano, P
    Rotman, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (05): : 1043 - 1047
  • [2] Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma
    Bedrosian, I
    Rodriguez-Bigas, MA
    Feig, B
    Hunt, KK
    Ellis, L
    Curley, SA
    Vauthey, JN
    Delclos, M
    Crane, C
    Janjan, N
    Skibber, JM
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (01) : 56 - 62
  • [3] Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - A meta-analysis
    Bipat, S
    Glas, AS
    Slors, FJM
    Zwinderman, AH
    Bossuyt, PMM
    Stoker, J
    [J]. RADIOLOGY, 2004, 232 (03) : 773 - 783
  • [4] Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients
    Bonnen, M
    Crane, C
    Vauthey, JN
    Skibber, J
    Delclos, ME
    Rodriguez-Bigas, M
    Hoff, PM
    Lin, E
    Eng, C
    Wong, A
    Janjan, NA
    Feig, BW
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (04): : 1098 - 1105
  • [5] Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy
    Bujko, K
    Nowacki, MP
    Nasierowska-Guttmejer, A
    Michalski, W
    Bebenek, AB
    Pudelko, M
    Kryj, A
    Oledzki, J
    Szmeja, J
    Sluszniak, J
    Serkies, K
    Kladny, J
    Pamucka, A
    Kukolowicz, P
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 72 (01) : 15 - 24
  • [6] Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation
    Chakravarti, A
    Compton, CC
    Shellito, PC
    Wood, WC
    Landry, J
    Machuta, SR
    Kaufman, D
    Ancukiewicz, M
    Willett, CG
    [J]. ANNALS OF SURGERY, 1999, 230 (01) : 49 - 54
  • [7] PREOPERATIVE RADIATION AND CHEMOTHERAPY IN THE TREATMENT OF ADENOCARCINOMA OF THE RECTUM
    CHARI, RS
    TYLER, DS
    ANSCHER, MS
    RUSSELL, L
    CLARY, BM
    HATHORN, J
    SEIGLER, HF
    [J]. ANNALS OF SURGERY, 1995, 221 (06) : 778 - 787
  • [8] Crane CH, 2004, RADIOTHER ONCOL, V73, pS149
  • [9] PREOPERATIVE OR POSTOPERATIVE IRRADIATION IN ADENOCARCINOMA OF THE RECTUM - FINAL TREATMENT RESULTS OF A RANDOMIZED TRIAL AND AN EVALUATION OF LATE SECONDARY EFFECTS
    FRYKHOLM, GJ
    GLIMELIUS, B
    PAHLMAN, L
    [J]. DISEASES OF THE COLON & RECTUM, 1993, 36 (06) : 564 - 572
  • [10] Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial
    Gerard, JP
    Chapet, O
    Nemoz, C
    Hartweig, J
    Romestaing, P
    Coquard, R
    Barbet, N
    Maingon, P
    Mahe, M
    Baulieux, J
    Partensky, C
    Papillon, M
    Glehen, O
    Crozet, B
    Grandjean, JP
    Adeleine, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2404 - 2409